Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.1049
S.1049: Opioid Addiction Risk Transparency Act
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced May 4, 2017
- Latest Major Action May 4, 2017
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in Senate - May 4, 2017
Bill Summary
Opioid Addiction Risk Transparency Act This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| May 4, 2017 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| May 4, 2017 |
Introduced in the Senate by Margaret Hassan (D-N.H.) |